Harga Saham
717.80
Perubahan Harian
7.20 1.01%
Bulanan
19.67%
Tahunan
37.25%
Q2 Perkiraan
666.18




Biaya Penjualan Perubahan Tanggal
AstraZeneca USD 3.27B 471M 2025-12
Galapagos EUR 455K 84.28M 2025-12
Genmab DKK 81M 23M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
GRIFOLS EUR 1.29B 163.12M 2025-12
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Qiagen NV USD 217.43M 29.65M 2025-12
UCB EUR 1.07B 146M 2025-12